Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Oct;88(4):1291–1299. doi: 10.1172/JCI115433

Role of L-thyroxine in nuclear thyroid hormone receptor occupancy and growth hormone production in cultured GC cells.

Y Halperin 1, L E Shapiro 1, M I Surks 1
PMCID: PMC295598  PMID: 1918379

Abstract

The contribution of L-thyroxine (T4) to nuclear thyroid receptor occupancy was studied in GC cells incubated with concentrations of 3,5,3'-triiodo-L-thyronine (T3) and T4 that resulted in free iodothyronine levels similar to those in serum of euthyroid rats. T4 accounted for 5.4-10% of the occupied receptors: T3 derived from T4 [T3(T4)] and T3 added to medium accounted for the remainder of receptor occupancy. Incubation with increasing medium free T4 resulted in a progressive increase in the contribution of T4 and T3(T4) to receptor occupancy. In incubations with 3.6-fold increased medium free T4, T4 accounted for 20.4%, and T3(T4) for 40.3% of receptor occupancy. These occupancy data and the experimentally determined Ka of thyroid receptor for T3 and T4 allowed calculation of nuclear free iodothyronine concentrations. Nuclear free T3 was 3-6-fold greater than medium free T3 and nuclear [corrected] free T4 was 12-19-fold greater than medium free T4. When GC cells were incubated with decreased medium free T3 and physiological medium free T4, both nuclear receptor occupancy and growth hormone production decreased as well. However, a twofold increase in medium free T4, in the presence of decreased medium free T3, restored receptor occupancy and growth hormone production to or near control values. These findings establish a role for T4 in addition to T3(T4) in nuclear receptor occupancy and biological activity in rat anterior pituitary tissue both in physiologic conditions and when medium free T4 is raised. The findings may have relevance to the sick euthyroid thyroid syndrome in which free T4 may be increased in some patients who have decreased serum free T3.

Full text

PDF
1291

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bermudez F., Surks M. I., Oppenheimer J. H. High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease. J Clin Endocrinol Metab. 1975 Jul;41(1):27–40. doi: 10.1210/jcem-41-1-27. [DOI] [PubMed] [Google Scholar]
  2. Braverman L. E., Ingbar S. H., Sterling K. Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest. 1970 May;49(5):855–864. doi: 10.1172/JCI106304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Crantz F. R., Silva J. E., Larsen P. R. An analysis of the sources and quantity of 3,5,3'-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology. 1982 Feb;110(2):367–375. doi: 10.1210/endo-110-2-367. [DOI] [PubMed] [Google Scholar]
  4. DeFesi C. R., Surks M. I. 3,5,3'-Triiodothyronine effects on the growth rate and cell cycle of cultured GC cells. Endocrinology. 1981 Jan;108(1):259–267. doi: 10.1210/endo-108-1-259. [DOI] [PubMed] [Google Scholar]
  5. Evans R. M. The steroid and thyroid hormone receptor superfamily. Science. 1988 May 13;240(4854):889–895. doi: 10.1126/science.3283939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Freake H. C., Mooradian A. D., Schwartz H. L., Oppenheimer J. H. Stereospecific transport of triiodothyronine to cytoplasm and nucleus in GH1 cells. Mol Cell Endocrinol. 1986 Jan;44(1):25–35. doi: 10.1016/0303-7207(86)90102-4. [DOI] [PubMed] [Google Scholar]
  7. GROSS J., PITT-RIVERS R. The identification of 3:5:3'-L-triiodothyronine in human plasma. Lancet. 1952 Mar 1;1(6705):439–441. doi: 10.1016/s0140-6736(52)91952-1. [DOI] [PubMed] [Google Scholar]
  8. Halperin Y., Shapiro L. E., Surks M. I. Medium 3,5,3'-triiodo-L-thyronine (T3) and T3 generated from L-thyroxine are exchangeable in cultured GC cells. Endocrinology. 1990 Sep;127(3):1050–1056. doi: 10.1210/endo-127-3-1050. [DOI] [PubMed] [Google Scholar]
  9. Halperin Y., Surks M. I., Shapiro L. E. L-triiodothyronine (T3) regulates cellular growth rate, growth hormone production, and levels of nuclear T3 receptors via distinct dose-response ranges in cultured GC cells. Endocrinology. 1990 May;126(5):2321–2326. doi: 10.1210/endo-126-5-2321. [DOI] [PubMed] [Google Scholar]
  10. Hay I. D., Annesley T. M., Jiang N. S., Gorman C. A. Simultaneous determination of D- and L-thyroxine in human serum by liquid chromatography with electrochemical detection. J Chromatogr. 1981 Dec 11;226(2):383–390. doi: 10.1016/s0378-4347(00)86072-7. [DOI] [PubMed] [Google Scholar]
  11. Hupart K. H., DeFesi C. R., Katz C. P., Shapiro L. E., Surks M. I. Differential response to L-triiodothyronine of anterior pituitary growth hormone messenger ribonucleic acid (mRNA) and beta-thyrotropin mRNA in a hypothyroid Walker 256 carcinoma-bearing rat model of nonthyroidal disease. Endocrinology. 1990 Jan;126(1):616–621. doi: 10.1210/endo-126-1-616. [DOI] [PubMed] [Google Scholar]
  12. Kinlaw W. B., Schwartz H. L., Oppenheimer J. H. Decreased serum triiodothyronine in starving rats is due primarily to diminished thyroidal secretion of thyroxine. J Clin Invest. 1985 Apr;75(4):1238–1241. doi: 10.1172/JCI111821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kochupillai N., Yalow R. S. Preparation, purification, and stability of high specific activity 125I-labeled thyronines. Endocrinology. 1978 Jan;102(1):128–135. doi: 10.1210/endo-102-1-128. [DOI] [PubMed] [Google Scholar]
  14. Koerner D., Schwartz H. L., Surks M. I., Oppenheimer J. H. Binding of selected iodothyronine analogues to receptor sites of isolated rat hepatic nuclei. High correlation between structural requirements for nuclear binding and biological activity. J Biol Chem. 1975 Aug 25;250(16):6417–6423. [PubMed] [Google Scholar]
  15. LASSITER W. R., STANBURY J. B. The in vivo conversion of thyroxine to 3:5:3'triiodothyronine. J Clin Endocrinol Metab. 1958 Aug;18(8):903–906. doi: 10.1210/jcem-18-8-903. [DOI] [PubMed] [Google Scholar]
  16. Larsen P. R., Silva J. E., Kaplan M. M. Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr Rev. 1981 Winter;2(1):87–102. doi: 10.1210/edrv-2-1-87. [DOI] [PubMed] [Google Scholar]
  17. MACLAGAN N. F., SPROTT W. E., WILKINSON J. H. Effect of 3:5:3-L-triiodothyronine and certain anti-thyroxine substances on the oxygen consumption of mice. Lancet. 1952 Nov 8;2(6741):915–916. doi: 10.1016/s0140-6736(52)91279-8. [DOI] [PubMed] [Google Scholar]
  18. Murray M. B., Zilz N. D., McCreary N. L., MacDonald M. J., Towle H. C. Isolation and characterization of rat cDNA clones for two distinct thyroid hormone receptors. J Biol Chem. 1988 Sep 5;263(25):12770–12777. [PubMed] [Google Scholar]
  19. Nakai A., Seino S., Sakurai A., Szilak I., Bell G. I., DeGroot L. J. Characterization of a thyroid hormone receptor expressed in human kidney and other tissues. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2781–2785. doi: 10.1073/pnas.85.8.2781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. OPPENHEIMER J. H., SQUEF R., SURKS M. I., HAUER H. BINDING OF THYROXINE BY SERUM PROTEINS EVALUATED BY EQUILIBRUM DIALYSIS AND ELECTROPHORETIC TECHNIQUES. ALTERATIONS IN NONTHYROIDAL ILLNESS. J Clin Invest. 1963 Nov;42:1769–1782. doi: 10.1172/JCI104862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Oppenheimer J. H., Schwartz H. L., Koerner D., Surks M. I. Limited binding capacity sites for L-triiodothyronine in rat liver nuclei. Nuclear-cytoplasmic interrelation, binding constants, and cross-reactivity with L-thyroxine. J Clin Invest. 1974 Mar;53(3):768–777. doi: 10.1172/JCI107615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Oppenheimer J. H., Schwartz H. L. Stereospecific transport of triiodothyronine from plasma to cytosol and from cytosol to nucleus in rat liver, kidney, brain, and heart. J Clin Invest. 1985 Jan;75(1):147–154. doi: 10.1172/JCI111667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Oppenheimer J. H., Schwartz H. L., Surks M. I. Propylthiouracil inhibits the conversion of L-thyroxine to L-triiodothyronine. An explanation of the antithyroxine effect of propylthiouracil and evidence supporting the concept that triiodothyronine is the active thyroid hormone. J Clin Invest. 1972 Sep;51(9):2493–2497. doi: 10.1172/JCI107063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pascual A., Montiel F., Aranda A. Effects of iopanoic acid on thyroid hormone receptor, growth hormone production, and triiodothyronine generation from thyroxine in pituitary GH1 cells. Endocrinology. 1987 Mar;120(3):1089–1096. doi: 10.1210/endo-120-3-1089. [DOI] [PubMed] [Google Scholar]
  25. Samuels H. H., Stanley F., Casanova J. Depletion of L-3,5,3'-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology. 1979 Jul;105(1):80–85. doi: 10.1210/endo-105-1-80. [DOI] [PubMed] [Google Scholar]
  26. Samuels H. H., Stanley F., Casanova J. Relationship of receptor affinity to the modulation of thyroid hormone nuclear receptor levels and growth hormone synthesis by L-triiodothyronine and iodothyronine analogues in cultured GH1 cells. J Clin Invest. 1979 Jun;63(6):1229–1240. doi: 10.1172/JCI109418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Samuels H. H., Tsai J. S., Casanova J., Stanley F. Thyroid hormone action: in vitro characterization of solubilized nuclear receptors from rat liver and cultured GH1 cells. J Clin Invest. 1974 Oct;54(4):853–865. doi: 10.1172/JCI107825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Samuels H. H., Tsai J. S. Thyroid hormone action in cell culture: domonstration of nuclear receptors in intact cells and isolated nuclei. Proc Natl Acad Sci U S A. 1973 Dec;70(12):3488–3492. doi: 10.1073/pnas.70.12.3488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Samuels H. H., Tsai J. S. Thyroid hormone action. Demonstration of similar receptors in isolated nuclei of rat liver and cultured GH1 cells. J Clin Invest. 1974 Feb;53(2):656–659. doi: 10.1172/JCI107601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sap J., Muñoz A., Damm K., Goldberg Y., Ghysdael J., Leutz A., Beug H., Vennström B. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature. 1986 Dec 18;324(6098):635–640. doi: 10.1038/324635a0. [DOI] [PubMed] [Google Scholar]
  31. Schwartz H. L., Surks M. I., Oppenheimer J. H. Quantitation of extrathyroidal conversion of L-thyroxine to 3,5,3'-triiodo-L-thyronine in the rat. J Clin Invest. 1971 May;50(5):1124–1130. doi: 10.1172/JCI106584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Silva J. E., Dick T. E., Larsen P. R. The contribution of local tissue thyroxine monodeiodination to the nuclear 3,5,3'-triiodothyronine in pituitary, liver, and kidney of euthyroid rats. Endocrinology. 1978 Oct;103(4):1196–1207. doi: 10.1210/endo-103-4-1196. [DOI] [PubMed] [Google Scholar]
  33. Silva J. E., Larsen P. R. Pituitary nuclear 3,5,3'-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine. Science. 1977 Nov 11;198(4317):617–620. doi: 10.1126/science.199941. [DOI] [PubMed] [Google Scholar]
  34. St Germain D. L. The effects and interactions of substrates, inhibitors, and the cellular thiol-disulfide balance on the regulation of type II iodothyronine 5'-deiodinase. Endocrinology. 1988 May;122(5):1860–1868. doi: 10.1210/endo-122-5-1860. [DOI] [PubMed] [Google Scholar]
  35. Sterling K., Brenner M. A., Newman E. S. Conversion of thyroxine to triiodothyronine in normal human subjects. Science. 1970 Sep 11;169(3950):1099–1100. doi: 10.1126/science.169.3950.1099. [DOI] [PubMed] [Google Scholar]
  36. Surks M. I., Hupart K. H., Pan C., Shapiro L. E. Normal free thyroxine in critical nonthyroidal illnesses measured by ultrafiltration of undiluted serum and equilibrium dialysis. J Clin Endocrinol Metab. 1988 Nov;67(5):1031–1039. doi: 10.1210/jcem-67-5-1031. [DOI] [PubMed] [Google Scholar]
  37. Surks M. I., Oppenheimer J. H. Concentration of L-thyroxine and L-triiodothyronine specifically bound to nuclear receptors in rat liver and kidney. Quantitative evidence favoring a major role of T3 in thyroid hormone action. J Clin Invest. 1977 Sep;60(3):555–562. doi: 10.1172/JCI108807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Surks M. I., Ramirez I. J., Shapiro L. E., Kumara-Siri M. Effect of zinc(II) and other divalent cations on binding of 3,5,3'-triiodo-L-thyronine to nuclear receptors from cultured GC cells. J Biol Chem. 1989 Jun 15;264(17):9820–9826. [PubMed] [Google Scholar]
  39. Surks M. I., Schadlow A. R., Oppenheimer J. H. A new radioimmunoassay for plasma L-triiodothyronine: measurements in thyroid disease and in patients maintained on hormonal replacement. J Clin Invest. 1972 Dec;51(12):3104–3113. doi: 10.1172/JCI107137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Surks M. I., Schadlow A. R., Stock J. M., Oppenheimer J. H. Determination of iodothyronine absorption and conversion of L-thyroxine (T 4 ) to L-triiodothyronine (T 3 ) using turnover rate techniques. J Clin Invest. 1973 Apr;52(4):805–811. doi: 10.1172/JCI107244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Thompson C. C., Weinberger C., Lebo R., Evans R. M. Identification of a novel thyroid hormone receptor expressed in the mammalian central nervous system. Science. 1987 Sep 25;237(4822):1610–1614. doi: 10.1126/science.3629259. [DOI] [PubMed] [Google Scholar]
  42. WILKINSON J. H., MACLAGAN N. F. Effect of an anti-thyroxine compound on the metabolism of radioactive thyroxine and triiodothyronine in rats. Lancet. 1953 Nov 14;265(6794):1024–1025. doi: 10.1016/s0140-6736(53)91312-9. [DOI] [PubMed] [Google Scholar]
  43. Wartofsky L., Burman K. D. Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome". Endocr Rev. 1982 Spring;3(2):164–217. doi: 10.1210/edrv-3-2-164. [DOI] [PubMed] [Google Scholar]
  44. Weinberger C., Thompson C. C., Ong E. S., Lebo R., Gruol D. J., Evans R. M. The c-erb-A gene encodes a thyroid hormone receptor. Nature. 1986 Dec 18;324(6098):641–646. doi: 10.1038/324641a0. [DOI] [PubMed] [Google Scholar]
  45. van Doorn J., van der Heide D., Roelfsema F. Sources and quantity of 3,5,3'-triiodothyronine in several tissues of the rat. J Clin Invest. 1983 Nov;72(5):1778–1792. doi: 10.1172/JCI111138. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES